Combination bacteriolytic therapy for the treatment of experimental tumors
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Current chemotherapeutic approaches for cancer are in part limited by the inability of drugs to destroy neoplastic cells within poorly vascularized compartments of tumors. We have here systematically assessed anaerobic bacteria for their capacity to grow expansively within avascular compartments of transplanted tumors. Among 26 different strains tested, one ( Clostridium novyi ) appeared particularly promising. We created a strain of C. novyi devoid of its lethal toxin ( C. novyi-NT ) and showed that intravenously injected C. novyi-NT spores germinated within the avascular regions of tumors in mice and destroyed surrounding viable tumor cells. When C. novyi-NT spores were administered together with conventional chemotherapeutic drugs, extensive hemorrhagic necrosis of tumors often developed within 24 h, resulting in significant and prolonged antitumor effects. This strategy, called co mbination ba cterio l ytic t herapy (COBALT), has the potential to add a new dimension to the treatment of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.
Brown, J. M., & Giaccia, A. J. (1998) · PubMed · Cited by 1,745
Delivery of molecular and cellular medicine to solid tumors
Jain, R. K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.011 · Cited by 774
Jain, R. K. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00131-9 · Cited by 529
Low, K. B., Ittensohn, M., Le, T., Platt, J., Sodi, S., Amoss, M., Ash, O., Carmichael, E., Chakraborty, A., Fischer, J., et al. (1999) · Nature Biotechnology · doi:10.1038/5205 · Cited by 476
Molecular genetics and pathogenesis of Clostridium perfringens
Rood, J. I., & Cole, S. T. (1991) · Microbiological Reviews · doi:10.1128/mmbr.55.4.621-648.1991 · Cited by 450
Clairmont, C., Lee, K. C., Pike, J., Ittensohn, M., Low, K. B., Pawelek, J., Bermudes, D., Brecher, S. M., Margitich, D., Turnier, J., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315497 · Cited by 355
Sweeney, C. J., Miller, K. D., Sissons, S. E., Nozaki, S., Heilman, D. K., Shen, J., & Sledge, G. W. (2001) · PubMed · Cited by 331
Malmgren, R. A., & Flanigan, C. (1955) · PubMed · Cited by 263
Yazawa, K., Fujimori, M., Amano, J., Kano, Y., & Taniguchi, S. (2000) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700122 · Cited by 241
Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment
Lemmon, M., van Zijl, P., Fox, M., Mauchline, M., Giaccia, A., Minton, N., & Brown, J. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300468 · Cited by 174
Fox, M. E., Lemmon, M. J., Mauchline, M. L., Davis, T. O., Giaccia, A. J., Minton, N. P., & Brown, J. M. (1996) · PubMed · Cited by 170
Use of preferentially replicating bacteria for the treatment of cancer
Sznol, M., Lin, S. L., Bermudes, D., Zheng, L.-M., & King, I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9818 · Cited by 170
Yazawa, K., Fujimori, M., Nakamura, T., Sasaki, T., Amano, J., Kano, Y., & Taniguchi, S. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1010644217648 · Cited by 161
Kimura, N. T., Taniguchi, S., Aoki, K., & Baba, T. (1980) · PubMed · Cited by 153
MOESE, J. R., & MOESE, G. (1964) · PubMed · Cited by 141
Interspecies Conversion of Clostridium botulinum Type C to Clostridium novyi Type A by Bacteriophage
Eklund, M. W., Poysky, F. T., Meyers, J., & Pelroy, G. A. (1974) · Science · doi:10.1126/science.186.4162.456 · Cited by 134
Pedley, R. B., Hill, S. A., Boxer, G., Flynn, A. A., Boden, R. W., Watson, R., Dearling, J. L. J., Chaplin, D. J., & Beǵent, R. H. J. (2001) · PubMed · Cited by 108
Effect of Histolyticus Infection and Toxin on Transplantable Mouse Tumors.
Parker, R. C., Plummer, H. C., Siebenmann, C. O., & Chapman, M. G. (1947) · Experimental Biology and Medicine · doi:10.3181/00379727-66-16124 · Cited by 107
Carey, R. W., Holland, J. F., Whang, H. Y., Neter, E., & Bryant, B. (1967) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(67)90060-6 · Cited by 104
Antitumor effect of Bifidobacterium infantis in mice.
Kohwi, Y., Imai, K., Tamura, Z., & Hashimoto, Y. (1978) · PubMed · Cited by 102
ONCOLYSIS BY CLOSTRIDIA. III. EFFECTS OF CLOSTRIDIA AND CHEMOTHERAPEUTIC AGENTS ON RODENT TUMORS.
Thiele, E. H., Arison, R. N., & Boxer, G. E. (1964) · PubMed · Cited by 81
Relationship of bacteriophages to alpha toxin production in Clostridium novyi types A and B
Eklund, M. W., Poysky, F. T., Peterson, M. E., & Meyers, J. A. (1976) · Infection and Immunity · doi:10.1128/iai.14.3.793-803.1976 · Cited by 63
Comparison of Clostridium sordellii toxins HT and LT with toxins A and B of C. difficile
MARTINEZ, R. D., & WILKINS, T. D. (1992) · Journal of Medical Microbiology · doi:10.1099/00222615-36-1-30 · Cited by 60
Gericke, D., & Engelbart, K. (1964) · PubMed · Cited by 58
Tsutsui, K., Minami, J., Matsushita, O., Katayama, S., Taniguchi, Y., NAKAMURA, S., Nishioka, M., & Okabe, A. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.24.7164-7170.1995 · Cited by 58
Improvement of Clostridium tumour targeting vectors evaluated in rat rhabdomyosarcomas
Theys, J. (2001) · FEMS Immunology and Medical Microbiology · doi:10.1016/s0928-8244(00)00231-5 · Cited by 50
Cited by
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Drug Resistance and the Solid Tumor Microenvironment
Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116
Garrett, W. S. (2015) · Science · doi:10.1126/science.aaa4972 · Cited by 1,404
Engineering the perfect (bacterial) cancer therapy
Forbes, N. S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2934 · Cited by 905
“For propulsion and sensing, bacteria have flagella that enable tissue penetratio”
Background
Metadata
- Authors
- Dang, L. H., Bettegowda, C., Huso, D. L., Kinzler, K. W., & Vogelstein, B.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2001-11-27
- Volume
- 98
- Issue
- 26
- Pages
- 15155-15160
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2046894146
- Cited by
- 563
- References
- 26
- FWCI
- 9.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.